CIBC Asset Management’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,069
| Closed | -$226K | – | 1537 |
|
|
2021
Q4 | $226K | Buy |
5,069
+186
| +4% | +$8.29K | ﹤0.01% | 1298 |
|
|
2021
Q3 | $246K | Buy |
4,883
+445
| +10% | +$22.4K | ﹤0.01% | 1168 |
|
|
2021
Q2 | $348K | Hold |
4,438
| – | – | ﹤0.01% | 923 |
|
|
2021
Q1 | $253K | Buy |
4,438
+827
| +23% | +$47.1K | ﹤0.01% | 1063 |
|
|
2020
Q4 | $302K | Buy |
+3,611
| New | +$302K | ﹤0.01% | 899 |
|